LAVIX TAB is a highly effective oral antiplatelet medicine, widely used in the prevention of thrombotic cardiovascular events. Its primary active ingredient, Clopidogrel Bisulfate, belongs to the class of medications known as P2Y12 platelet inhibitors, which function by irreversibly blocking adenosine diphosphate (ADP) receptors on the platelet surface. This action prevents platelets from clumping together and forming harmful blood clots inside arteries, especially those already narrowed by atherosclerosis.

The medication is essential in the secondary prevention of myocardial infarction (heart attack), ischemic stroke, and other vascular conditions in patients with a history of such events or with established peripheral arterial disease. It is also commonly prescribed after coronary stenting or bypass surgery to reduce the risk of stent thrombosis.

LAVIX TAB is typically well tolerated and is known for its oral convenience and long-lasting antiplatelet effect. It is frequently co-prescribed with low-dose Aspirin in dual antiplatelet therapy (DAPT) protocols to enhance cardiovascular protection in high-risk individuals. The standard dosage and duration of treatment depend on the specific medical condition, patient profile, and concurrent therapies.

Each batch of LAVIX TAB manufactured by BLUEPILL EXPRESS adheres to rigorous GMP and WHO-certified manufacturing standards. The tablets are formulated using pharmaceutical-grade Clopidogrel with precise dosage accuracy and high bioavailability to ensure optimal patient outcomes. Strict quality control processes are employed at every stage, from raw material sourcing to finished product packaging, to ensure safety, efficacy, and shelf stability.